- Home
- PFO vs ORMP Comparison
PFO vs ORMP Comparison
Compare PFO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- ORMP
- Stock Information
- Founded
- PFO 1991
- ORMP 2002
- Country
- PFO United States
- ORMP United States
- Employees
- PFO N/A
- ORMP N/A
- Industry
- PFO Finance Companies
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- PFO Finance
- ORMP Health Care
- Exchange
- PFO Nasdaq
- ORMP Nasdaq
- Market Cap
- PFO 127.2M
- ORMP 104.6M
- IPO Year
- PFO N/A
- ORMP N/A
- Fundamental
- Price
- PFO $9.65
- ORMP $2.36
- Analyst Decision
- PFO
- ORMP
- Analyst Count
- PFO 0
- ORMP 0
- Target Price
- PFO N/A
- ORMP N/A
- AVG Volume (30 Days)
- PFO 31.8K
- ORMP 126.1K
- Earning Date
- PFO 01-01-0001
- ORMP 11-06-2025
- Dividend Yield
- PFO 6.51%
- ORMP N/A
- EPS Growth
- PFO N/A
- ORMP N/A
- EPS
- PFO N/A
- ORMP N/A
- Revenue
- PFO N/A
- ORMP $2,000,000.00
- Revenue This Year
- PFO N/A
- ORMP N/A
- Revenue Next Year
- PFO N/A
- ORMP N/A
- P/E Ratio
- PFO N/A
- ORMP N/A
- Revenue Growth
- PFO N/A
- ORMP N/A
- 52 Week Low
- PFO $6.90
- ORMP $1.82
- 52 Week High
- PFO $8.51
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- PFO 47.50
- ORMP 50.67
- Support Level
- PFO $9.58
- ORMP $2.19
- Resistance Level
- PFO $9.79
- ORMP $2.47
- Average True Range (ATR)
- PFO 0.12
- ORMP 0.12
- MACD
- PFO -0.03
- ORMP -0.03
- Stochastic Oscillator
- PFO 23.11
- ORMP 44.74
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.